A close look at Florida’s economy shows just how vulnerable the state and its population are to a pandemic, and some of the reasons state officials hesitate to take action.
Changes caused by COVID-19 in the higher education sector could alter the power dynamics between African researchers and those from developed countries.
Nicole Hassoun, Binghamton University, State University of New York
The high cost of pharmaceuticals often means only the richest patients get lifesaving medicines. As coronavirus drugs emerge, it will require hard, creative work to ensure they’re available to all.
Nir Kshetri, University of North Carolina – Greensboro
As colleges and universities strive to protect their campuses from COVID-19, they must also pay attention to cyberattacks that target sensitive data, a cybersecurity expert warns.
Universities have financial resources — property, bequests and philanthropic funds, and access to lines of credit — they can access rather than forcing staff to sacrifice their jobs.
With COVID-19 spreading in Sydney’s southwest, can New South Wales avoid a return to lockdown and a similar scenario to Victoria’s second wave? The answer depends on whether there is community spread.
If you’ve got a test but haven’t heard back, it’s possible the delay is caused by test samples needing to be taken to interstate labs and the huge scale of testing underway.
With regular music festivals, people can more easily seek help or advice about drug and alcohol or mental health issues. But with drive-ins we need to be creative to minimise harms.
Experts are currently debating whether Australia should pursue its current suppression strategy, or switch to an elimination strategy instead. But how different are the two?
No single measure in isolation prevents disease transmission. It is a matter of reducing the likelihood and enhancing the capacity of the system to deal with events that occur.
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand